ProteoFormiX
Leuven, BE · 1 known investors
Find your way into ProteoFormiX
Sign up to see every warm intro you have to ProteoFormiX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ProteoFormiX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ProteoFormiX applies top-down proteomics to biobanked clinical tissue and liquid biopsy samples to identify human proteoforms and discover biomarkers for drug development and diagnostics. It focuses on neurodegenerative disorders, hard-to-diagnose diseases such as cancer, and biofluid-based proteomics (e.g. tears in ophthalmology), working with hospital pathology departments and pharmaceutical research groups.
Founders & leadership
Investors · 1
Frequently asked questions
- What does ProteoFormiX do?
- ProteoFormiX applies top-down proteomics to biobanked clinical tissue and liquid biopsy samples to identify human proteoforms and discover biomarkers for drug development and diagnostics. It focuses on neurodegenerative disorders, hard-to-diagnose diseases such as cancer, and biofluid-based proteomics (e.g. tears in ophthalmology), working with hospital pathology departments and pharmaceutical research groups.
- Who founded ProteoFormiX?
- ProteoFormiX was founded by Peter Verhaert.
- Who are ProteoFormiX's investors?
- ProteoFormiX's investors include imec.istart.
- Where is ProteoFormiX headquartered?
- ProteoFormiX is headquartered in Leuven, BE.
